Date 1997-10-29


Hernqvist, Per Håkan Erik
Born: 1950-01-09
Address: Alfhöjdsgatan 6, 431 38 Mölndal
Telephone: 031-160683 mobile 0709-670009
Profile and qualities:

I have worked in the pharmaceutical business for 39 years, first within marketing and the last 30
years within clinical research. In this area I have conducted all moments within clinical trials, from
protocol development to report and publication. I have also been responsible author of an expert
report and a study summary in an application for a new indication. I have been monitoring studies
for 17 years and in parallel been heading a clinical research department with the responsibility for
all phase II-IV studies within the Gastrointestinal Area (Losec and Nexium) in Sweden for
AstraZeneca during 1983-2003. Year 2003 AstraZencea changed to a more generic, non
therapeutic area managed, organization and my job became more focused on line management
and coaching of coworkers (18 persons during 2009).
After leaving AstraZeneca in 2010 I have had several various assignments through my own
consultant agency, among others at Mölnlycke Health Care, Quintiles and Abigo Medical.
My strength is to see complex issues from a practical point of view, simplifying work while
maintaining quality standards according to ICH or SOPs.
I am a diplomatic person, having the ability to communicate difficult matters in a positive way, and
also having the ability to encourage and motivate other people to develop and do more than is
expected from them.
Full clinical trial services provider through own consultant agency 2010- Dep Clinical Operations: Clinical Operations Manager 2006-2010 Dep Global Clinical Trials: Director 2004-2006 Dep Clinical Research Gastrointestinal: Director 1999-2003 Medical department: Associate Director 1985-1999 Medical department: Clinical research scientist 1983-85 Marketing department: Sales manager 1979-83 Marketing department: Sales representative 1976-77 Marketing department: Sales representative 1974-76 Spångbergsgymnasiet, Filipstad: Supply teacher 1974
Lund University: Bachelor of Science 1973; Chemistry & Biology Olympiaskolan, Helsingborg: Upper secondary school; 3 years natural sciences; Higher certificate 1969
Military Service:

Artillery: Quartermaster; Sergeant, 1969, 1970-71 (in total 15 months)

Postgraduate education:

Limnology 10p 1973
Nature Conservation 10p 1973
RUFI education for representatives in pharmaceutical industry 1974
Medical statistics 10p 1989
Various courses:

Apotekarsocieteten: Site audits, 2006 (2 days)
Dale Carnegie: Communication and Leadership, 2005 (10 weeks 1 day/week)
Management i Lund: MiL International Partnership, 2000-2001 (5 weeks + project work)
Dynargie: People Management, 1998-99 (3+2+2+2 days)
UGL: Development of Group and Leader, 1997 (One week)
ASTRA: Data Editing and Source Data Validation 1996 (3 days)
IFL: Marketing 1983 (3 weeks + project work)
Professional societies:

Apotekarsocieteten; Föreningen för klinisk läkemedelsprövning
Language skills.

English: Very good
German: Good
IT knowledge:

Good knowledge of Microsoft Office
Have within AstraZeneca worked with several internal IT systems and in connection with the
reorganisation 2009-10 led a work stream structuring e-Room and Intranet for the new AZ
Nordic organisation.
System owner of IMPACT in Sweden (AstraZeneca´s Clinical Trials Monitoring System) 2003-


Dahlgren S, Domellöf L, Hradsky M et al. The effects of omeprazole and cimetidine on duodenal ulcer healing and the relief of symptoms. Aliment Pharmacol Ther 1988;2 483-92 Lind T, Haglund U, and Hernqvist H. Omeprazole or ranitidine for two or four weeks in duodenal ulcer patients: effect on healing, symptoms, and ulcer recurrance during intermittent short term treatment. Gut 1989;30:A 1488 (Abstract) Kager L, Lindberg G, Nilsson L H et al. The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms, and incidence of adverse events in the treament of duodenal ulcer patients. Hepatogastroenterology 1991;38:4 287-90 Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Quality of Life in Patients with Upper Gastrointestinal Symptoms. An Improved Evaluation of Treatment Regimens? Scand J Gastroenterol 1993;28:681-687 Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and
gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal
ulcer. Scand J of Gastroenterol 1995;30:1046-1052
Lind T, Havelund T, Carlsson R, Glise H, Hernqvist H, Junghard O et al. The effect of
omeprazole 20 mg and 10 mg daily on heartburn in patients with endoscopy negative reflux
disease. Gastroenterolgy 1995;103: A 192
Johnsson F, Weywadt L, Solhaug J-H, Hernqvist H, Bengtsson L. One week omeprazole
treatment in the diagnosis of gastroesophageal reflux. Gut 1996:39 (suppl 1) T 155
Lind T, Havelund T, Carlsson R, Glise H, Hernqvist H, Junghard O et al. Heartburn without
esophagitis: efficacy of omeprazole therapy and features determining therapeutic response.
Scand J Gastroenterol 1997;32:974-979
Johnsson F, Weywadt L, Solhaug J-H, Hernqvist H, Bengtsson L. One week omeprazole
treatment in the diagnosis of gastroesophageal reflux. Scand J Gastroenterol 1998:34:15-20


Wife: Kerstin
Daughter: Elisabeth (born 88)
Sons: Fredrik (born 90) and Joakim (born 95)
Music (plays the clarinet in a jazz band)
Down-hill skiing
Bird Watching


Sven Karlsson, Facilities Director Mölndal, Sweden Business Services,
Astra Zeneca AB, Mölndal, Phone +46 (0)31 7763660, Mobile +46 761 256 761
Carin Fellenius, Site Management & Monitoring Director Western EU Södertälje,
Phone +46 (0)8 55323053
Peter Asplund, Director Clinical Operations Sweden and Norway, Managing Director,
Quintiles AB, Uppsala, Phone +46 18 4311114, Mobile + 46 733 319 114


Microsoft word - notification about convening annual general meeting of b3system jsc.docx

Notification about convening Annual General Meeting of B3System jsc Management Board of B3System jsc with registered office in Warszaw on the basis of art.399 § 1 k.s.h. in according with art. 4021, 4022 k.s.h. and § 12 ust. 3 Article of Association, convene an General Meeting on 23 April 2010 at 11:00 am. The Assembly will be held in the company's headquarters in Warsaw at Taneczna 7. 1. O

Microsoft word - 2012 nys pertussis fact_sheet

Pertussis, or whooping cough, is a highly contagious bacterial infection that causes an uncontrollable, violent cough lasting several weeks or even months. It is caused by a bacterium that is found in the mouth, nose and throat of an infected person. Pertussis may begin with cold-like symptoms or a dry cough that progress to episodes of severe coughing. Pertussis can occur at any age. Children wh

© 2010-2018 PDF pharmacy articles